Bivalirudin (Dr. Reddy’s Laboratories Limited)
Welcome to the PulseAid listing for the Bivalirudin drug offered from Dr. Reddy’s Laboratories Limited. This Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Dr. Reddy’s Laboratories Limited |
NON-PROPRIETARY NAME: | Bivalirudin |
SUBSTANCE NAME: | BIVALIRUDIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] |
ROUTE: | INTRACAVERNOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-05-31 |
END MARKETING DATE: | 0000-00-00 |
Bivalirudin HUMAN PRESCRIPTION DRUG Details:
Item Description | Bivalirudin from Dr. Reddy’s Laboratories Limited |
LABELER NAME: | Dr. Reddy’s Laboratories Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 2017-05-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55111-652_dcce401c-8b96-6ede-ae53-bf7b60d79f13 |
PRODUCT NDC: | 55111-652 |
APPLICATION NUMBER: | ANDA201577 |
Other BIVALIRUDIN Pharmaceutical Manufacturers / Labelers: